Keeping up with the pace of technology in an evolving field of innovation

Alberto Santagostino, Lonza Pharma & Biotech's SVP Cell and Gene Technologies delivers a keynote presentation at Phacilitate Leaders World 2019 in Miami

What’s Next for Commercial Cell Therapy Manufacturing?

Panellists from Invetech, bluebird bio, Juno Therapeutics and Hitachi Chemical Advanced Therapeutics Solutions (HCATS) discuss their vision for the coming era of industrialised cell therapy production at Phacilitate Leaders World 2019, Miami.

The Top Ten Events in Advanced Therapies 2018

From CRISPR patent wars, IPOs and acquisitions to major deals in China; what would be on your top ten list of 2018?

[INTERVIEW] An Academic Perspective on Cell Therapy, Trial Design...

An interview with Dr David Courtman of the Ottawa Hospital, the University of Ottawa and Northern Therapeutics

Preparing for Commercialisation with the Right CDMO

An interview with J. Kelly Ganjei, CEO and Chairman of the Board, Cognate BioServices, Inc

Building Manufacturing Infrastructure for Cell and Gene Therapies

The production shortfall for cell therapies and viral vectors could have a devastating effect on the growth and success of...

Raman Spectroscopy: A New Analytical Technique to Ensure the...

As we see more cell and gene therapies gaining market authorisation, attention is turning to the bioprocesses used for their...

Video: Gaining a Competitive Edge Through Effective Process Design...

Episode three in the top tips series is with Ohad Karnieli, CEO and Co-founder of ATVIO Biotechnology. Ohad gives his...

How do you Solve a Problem Like Cell Therapy Manufacturing?

The Automation SIG is a platform to debate, collaborate and work towards genuine solutions for the new paradigm of...

Cell and Gene Therapy Manufacturing Capacities in North America

Phacilitate's annual cell and gene therapy manufacturing capacities review reaches North America. Brought to you in partnership with...

VIDEO: Automation is Nothing Without Collaboration

This collaborative panel, filmed at Phacilitate Leaders World 2018 in Miami, reviews the 2017 Automation SIG. Experts from CGTC, Novartis,...

Cell and Gene Therapy Catapult

The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy...

The ROI of Automation in Cell-based Therapy Bioprocessing and...

Phacilitate and Biolacuna have produced a cutting-edge report, which includes the results, data and analysis of an industry-wide survey, plus...

Part Five: Commercialisation

The supply chain story concludes with a focus on commercialisation and scale-up

Part Four: Cryopreservation

This report provides a comprehensive guide to successfully investing in advanced therapies. It also outlines across six chapters each of the...

1
2
next
last